for Dec 06, 2019 through Dec 12, 2019
6,092,411 penicillin courses, 37,039 (0.61%) new "allergy" reports and only 25 (1 in 1482 "allergies") confirmed anaphylaxis.
— Eric Macy (@EricMacyMD) December 11, 2019
Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: A retrospective population-based study https://t.co/D8QKxCFBY8
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the @esicm and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP) | SpringerLink https://t.co/I4kj80e6NR
— Intens Care Med (@yourICM) December 6, 2019
NEW🔥 in OFID @canuckIDpharm @IDPharmProf @ClaeysKcclaeys
— Antibiotic Steward (@ABsteward) December 6, 2019
Real-world experience with ceftazidime-avibactam for multidrug-resistant gram-negative bacterial infections. #IDTwitter https://t.co/7aBw98A2xw pic.twitter.com/h61tUbvVtT
If you are interested in 🆔@IDstewardship & @ABsteward
— Antibiotic Steward 🆔 (@ABsteward) December 10, 2019
identify new infectious diseases & antimicrobial stewardship literature released each month.🔥🔥off the press & put together in one place.
Check out our December post #IDTwitter #ASHP19 #twitterx https://t.co/4oOTOPg51V
Add this one
— Antibiotic Steward 🆔 (@ABsteward) December 12, 2019
NEW Review Article 🔥🔥 @NEJM
Dr. Mariana Castells Penicillin Allergy. #IDTwitter #medtwitter #FOAMed cc @Bruce_M_Jones @TrubianoJason @PharmerMeg @PCN_Allergy @CAAR_Aus a must read for #pharmacists #ASHP19 https://t.co/Ete9LNfaIo pic.twitter.com/4mxskE0uWz
The sheer scope of the damage caused by measles as reported in the recent paper was really quite shocking to me. I wrote this in disbelief if anyone wants to read more about the science behind it https://t.co/bGbKbARw0M
— Dr Vicky Forster (@vickyyyf) December 6, 2019
NEW🔥 in #JACnews Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study. #IDTwitter https://t.co/bTdKuXhfjV pic.twitter.com/5QMNw4NUuI
— Antibiotic Steward 🆔 (@ABsteward) December 12, 2019
NEW 🔥🔥 @bmj_latest @BMJBestPractice
— Antibiotic Steward 🆔 (@ABsteward) December 12, 2019
Antibiotic prescribing without documented indication in ambulatory care clinics: national cross sectional study. #IDTwitter #medtwitter thanks @IDstewardship for sharing this important resource. https://t.co/wOG3DDO3gB pic.twitter.com/vxeV8JZ7cu
Thrice-weekly dosing for Ertapenem in patients receiving Hemodialysis? Check out this PK study of Ertapenem in HD patients receiving consecutive doses.
— SIDP (@SIDPharm) December 12, 2019
Full article here: https://t.co/OF0rKkzPgg#IDTwitter pic.twitter.com/4ENtxsHQgd
NEW🔥🔥CID @deannabuehrle @ClancyNeil @NateShivelyMD @Brookeholderia @IDPittStop
— Antibiotic Steward (@ABsteward) December 9, 2019
A multi-faceted Stewardship Intervention achieved Sustained ⬇️ in Overall & Unnecessary Antibiotic Prescribing at Primary Care Clinics in a VAHS. #IDTwitter #VAStewies https://t.co/Z7UmTjXgaB pic.twitter.com/bWr1pUE0jp
Impact of a comprehensive antimicrobial stewardship program on institutional burden of antimicrobial resistance: a 14-year controlled interrupted time series study https://t.co/qz2fkB3WfK
— Stanford ASP Team (@StanfordASP) December 11, 2019
A 14-year interrupted time series found implementation of an #antimicrobialstewardship program was associated with a reduction in AMR despite an increase in resistance in the community https://t.co/piZ6p87KDK
— Brad Langford (@BRxAD) December 10, 2019
NEW PODCAST🎙️Experts discuss #antimicrobialstewardship changes including @CMSGov’s new Condition of Participation requirement & @CDCgov’s revised Core Elements. Learn how to apply them in your practice. https://t.co/HMs9Zrhr20 #DISARMSuperbugs pic.twitter.com/KmMyHLJnbT
— IDSA (@IDSAInfo) December 11, 2019
🔥 🔥 🔥
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) December 8, 2019
Hot stuff! Here is the latest from @ABsteward and I, a rundown of new 📄 pubs that hit the interwebs in the last month.
Please share widely! There is so much 🤓 good stuff here.https://t.co/ER23kHkmCG #IDtwitter
cc: @idpharmd @CIDRAP_ASP @UGotABug @NorthwesternMed pic.twitter.com/jmWfwNRiml
A NEW 🔥🇪🇸multicentre study found that the implementation of a structured evidence-based intervention bundle significantly improved patient care and was ultimately associated with a ⬇️ in early & overall mortality of patients with candidaemia. #IDTwitter https://t.co/7QYttw6U5P pic.twitter.com/ddelCH8tNI
— Antibiotic Steward 🆔 (@ABsteward) December 10, 2019
New podcast 🎙 discussing #antimicrobialstewardship changes including @CMSGov new CoP & @CDCgov revised Core Elements. Learn how to apply to your practice. https://t.co/WdpkUFGlm1 via @IDSAInfo @JohnLynchID @UofUHealth
— Emily Sydnor Spivak (@EmilySpivak) December 11, 2019
Sulopenem Narrowly Misses Primary End Point in Phase 3 cIAI Study. (SURE) 3 RCT.
— Antibiotic Steward 🆔 (@ABsteward) December 12, 2019
#IDTwitter
Are these results disappointing in the lens of antibiotic stewardship? 🤔https://t.co/dK3uhFTjuT pic.twitter.com/UnCjzTjydO
A NEW🔥retro. study @InfectDis_Ther
— Antibiotic Steward (@ABsteward) December 6, 2019
Discontinuing ceftaroline following bacteremia resolution in patients with vanco/dapto-refractory MRSA bacteremia resulted in NO statistically significant difference in treatment.
An RCT would be worthwhile 🤔 #IDTwitter https://t.co/b6WAxniN9I
Can changing the way lab results are reported lead 👩⚕️👨⚕️ prescribers towards better decisions? Hear here from @BRxAD 🤓
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) December 8, 2019
Nudging and the 🔬🧫 microbiology lab is discussed here’s.
👉 https://t.co/kmg5NlULyT #IDstewardship #IDtwitter pic.twitter.com/Al7GenhTtM
I am glad the a publication related to antibiotic stewardship 👾💊 won as an innovation in pharmacy practice. A message to residents to not underestimate your residency project 💪
— Antibiotic Tweets (@khalideljaaly) December 9, 2019
Award link (include a link to the freely available article PDF): https://t.co/0OPwCyBIA8
'New antibiotics target outer membrane of bacteria' #StopSuperbugs https://t.co/OHuXswHQPm
— Antibiotic Action (@TheUrgentNeed) December 10, 2019
'Public health interventions designed to limit the burden of antimicrobial resistance should also consider determinants of poverty & inequality, especially in lower-middle income & low income countries' #JACNews https://t.co/BEJrvuEJJW
— BSAC (@BSACandJAC) December 10, 2019
#AntimicrobialStewardship at end-of-life should address family confidence in resident well-being, should highlight that stewardship improves care, and can be facilitated by accreditation standards
— Brad Langford (@BRxAD) December 8, 2019
🆕 in @AJICJournalhttps://t.co/ApsGQaGMwA
The Story of #Vitamin Ahttps://t.co/r5EHJ8piAB
— LotusOak (@LotusOak2) December 8, 2019
"Even mild vit A deficiency (VAD) dramatically increases childhood mortality rates, primarily b/c VAD reduces resistance to infectious diseases such as #measles & #diarrhea."
MALNOURISHMENT is #1 reason of deaths in 3rd World.
New article by @SIDPharm members @TimbrookTT & @pillsandskills on impact of ASP bundle for uncomplicated Gram-negative bacteremia.
— SIDP (@SIDPharm) December 12, 2019
Results:
ASP bundle associated with reduced durations of therapy and earlier PO switch.
Full article here: https://t.co/aFAaR2fNBy#IDTwitter pic.twitter.com/Nbq2nc3eZa
Enrol on our fully funded @rpharms #AMS Training Programme, starting 30th Jan 2020! Be supported by experts from @UKCPAPIN
— Beth Ward (@_Beth_Ward) December 10, 2019
Join the global fight against #AMR now!https://t.co/JTCAao2Mrt pic.twitter.com/v6J7hl3wfr
This is why OFID allows papers to be submitted in any format that can be easily opened and read by others. You don't need to reformat before submitting! @IDSAInfo @OUPAcademic https://t.co/aFoXZNwI62 https://t.co/5pJP5ssQEN pic.twitter.com/UygrcUTBgA
— Paul Sax (@PaulSaxMD) December 8, 2019
Should be a great webinar on #nurse role in #antimicrobialstewardship The Central Steward: Exploring the Role of Nursing in Antibiotic Stewardship @castrocloud @jomcewen1977 @steed1202 @PGallagherIEHG @stjamesdublin @CIDRAP_ASP https://t.co/mBnISHik5B
— Gerry Hughes (@astghughes) December 6, 2019
On BacterioFiles: Cyanobacteria infected by viruses continue taking up nutrients from their environment, using it to make more viruses than would otherwise be possible!https://t.co/zhn95jAXwE
— ASM (@ASMicrobiology) December 8, 2019
“Nearly all US hospitals now have an antibiotic stewardship program. However, many hospitals, especially smaller hospitals, appear to struggle with access to ID expertise and with deploying diagnostic stewardship strategies.” #opportunity https://t.co/fzCOQdKt5I
— Michael Calderwood (@CalderwoodMD) December 11, 2019
Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia | Clinical Infectious Diseases | Oxford Academic https://t.co/Z9PBqE2wlA
— Federico Palacio (@fedepalacio79) December 6, 2019
NEW🔥 retrospective 🇸🇬 study in IJAA Compared to carbapenem therapy, empiric TZP & definitive FEP were not associated w 30-day mortality in AmpC producing Enterobacterales bacteraemia. #IDTwitter @ischemo https://t.co/Jwr3gW8xVa https://t.co/hKgdBn5TWj
— Antibiotic Steward 🆔 (@ABsteward) December 11, 2019
This is a great commentary on the CAP guidelines, and should be attached to the guidelines. Thanks @EmilySpivak @ValeriaFabreMD @SaraKellerMD1
— Andrew Pavia (@AndrewPaviaMD) December 6, 2019
Viewing the CAP Guidelines Through an Antibiotic Stewardship Lens https://t.co/lGsbv99FNh
14-year study demonstrates impact of stewardship on antimicrobial resistance. MAD-ID is incredibly proud to have supported Sandra Walker et al’s work. https://t.co/GGc69Lyzzh
— MAD-ID The Antimicrobial Stewardship Meeting (@MAD_ID_ASP) December 10, 2019
Latest trends and treatments based on bacteriophages for MRSA in hospitals: a @JClinMicro minireview https://t.co/0GsPYX0PE6 #ASMClinMicro pic.twitter.com/jUKuExdJT2
— ASM (@ASMicrobiology) December 11, 2019
Bad news this week on #antibiotic use in USA. First, we learn ABX use up ~10% in food animals & now a new study finds: up to 43% of U.S. antibiotic prescriptions for people may be “inappropriate". We need to get our act together. https://t.co/PJsKBtCHag #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) December 12, 2019
NEW 🔥 in OFID
— Antibiotic Steward (@ABsteward) December 7, 2019
SA BSI in patients with prosthetic joint included in the prospective VIRSTA cohort study: frequency and time of occurrence of PJI. #IDTwitter https://t.co/hZ8mGu0eaS pic.twitter.com/J8fQLXR65u
'The decreasing antibiotic susceptibility of bacterial pathogens calls for novel antimicrobial therapies. Traditional screening pathways based on drug–target interaction have gradually reached the stage of diminishing returns' #JACNews https://t.co/HAazRUEHkn
— BSAC (@BSACandJAC) December 9, 2019
Yes I periodically get pedicures.
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) December 8, 2019
Yes the whole time I think about potential rapidly growing mycobacterium infections.
Yes the fact I do not shave my legs does make me feel better. https://t.co/2ViFd5h3hV
What color should I go with? Serratia red? pic.twitter.com/nF18MlGxL2
Azithromycin protects against Zika virus infection by upregulating virus-induced type I and III interferon responses #AACJournal https://t.co/3WrY6frF1O pic.twitter.com/CgJKO8pY7W
— ASM (@ASMicrobiology) December 11, 2019
In a 14 year interrupted time series analysis assessing the impact of a comprehensive hospital-based ASP, antibiotic resistant bacteria in community onset infections rose, while those in hospital onset infections declined. #StewardshipWorks https://t.co/GXPlBk2LEi
— Michael Calderwood (@CalderwoodMD) December 11, 2019
Ribavirin for Hepatitis E Infection After Organ Transplantation: A Large European Retrospective Multicenter Study | Clinical Infectious Diseases. Take home - ribavirin very effective in chronic HEV patients. Q is what to do with the 11%? @EASLedu https://t.co/G0F4cRYvZ7
— Ahmed Elsharkawy (@aelsharkawy75) December 6, 2019
#InfectiousDiseases A-Z: #TickBorneDiseases in the U.S. have tripled in recent years, according to the @CDCgov. A new study says a warming climate and other environmental changes may play a role in expanding the regions where ticks can be found. https://t.co/y9Iuhog0ov pic.twitter.com/xag6iCMNig
— Mayo Clinic (@MayoClinic) December 11, 2019
This winter there have been 424 cases of #H7N9 #birdflu in humans, more than 1/3 of all those identified since the virus emerged in 2013.
— Microbes&Infection (@MicrobesInfect) December 11, 2019
H7N9 seems to jump to people from poultry more easily than H5N1, staging regular winter outbreaks in the last 4 yrs.https://t.co/DO89gu6LfO pic.twitter.com/4YScowqMDI
Enrol on our fully funded #AMS Training Programme!
— Royal Pharmaceutical Society (@rpharms) December 12, 2019
Learners are supported with face to face training, self directed and group learning.
Led by experts from @UKCPAPIN
Book you place now. Fight against antimicrobial resistance#AMR https://t.co/W0SDncQUoK pic.twitter.com/BWz13ElRA7
Smart and clear assessment of sample sizes needed to power parallel CRTs on ICP /stewardship intervention in hospitals https://t.co/SkyYofwZY5
— Evelina Tacconelli (@EveTacconelli) December 12, 2019
What's on Your Antimicrobial Stewardship "Wish List"? #IDTwitter https://t.co/utWesopb7I via @Contagion_Live @eking1122 @Dimple__Patel
— Antibiotic Steward 🆔 (@ABsteward) December 11, 2019
Interested in using genomics to better understand bloodstream infections in children? Here's a PhD opportunity for you! Join our dynamic clinical research team @UQMedicine with @adamdirwin @davidantibiotic https://t.co/GAjQlrUqVX
— Patrick Harris (@padstamundo) December 12, 2019
From @STCmicrobeblog: You may be wondering why a group of 19 researchers is needed to characterize three humble bacteria? Three reasons... https://t.co/TQrU92SBCP
— ASM (@ASMicrobiology) December 11, 2019
Fewer than 50% of hospital trusts in England managed to reduce their #antibiotics consumption between 2017/2018 & 2018/2019. In our December feature we talk to some of the trusts who did to find out their secrets to antimicrobial stewardship success: https://t.co/jh2tvlBZw3
— Julia Robinson (@robinson_julia) December 6, 2019
DYK: Bacteria that have developed resistance to #antibiotics can multiply and spread from person to person? Find out more: https://t.co/gxMf9ITDZN via @USATODAY
— Save Antibiotics (@saveantibiotics) December 6, 2019
Created by Cameron Forbes. Last updated December 13, 2019 at 05:08 EST.